Skip to content

Fighting to Preserve the Benefits of the 340B Program

  • About Us
  • Contact Us
Top Bar Menu
Facebook page opens in new windowTwitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
    • Webinars
  • News
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
    • Webinars
  • News

Eighth Circuit Issues Favorable ERISA Preemption Decision that Likely Protects State 340B Anti-Discrimination Laws

Drug Pricing, News, RulingsBy Andrea JeriaNovember 19, 2021

On November 17, the U.S. Court of Appeals for the Eighth Circuit (Eighth Circuit) issued its decision in Pharmaceutical Care Management Association v. Wehbi, et al., ruling that North Dakota’s…

courthouse g329b35186 1280

Update on 340B Contract Pharmacy Litigation — Decisions Issued in Four Manufacturer Lawsuits

Drug Pricing, HHS, HRSA, News, RulingsBy Andrea JeriaNovember 8, 2021

On Friday, November 5, two federal courts issued decisions in four of the lawsuits that drug manufacturers filed against HHS challenging HHS’ May 17 cease-and-desist letters (“May 17 Letters”) notifying…

index

Indiana Federal Court Issues Decision in Eli Lilly’s Contract Pharmacy Lawsuit

Drug Pricing, HHS, HRSA, News, Rulings, RWC-340BBy Andrea JeriaNovember 1, 2021

On Friday, the U.S. District Court for the Southern District of Indiana (the Court) issued a decision supporting HRSA’s statutory interpretation, as reflected in HRSA’s May 17 determination, that Eli…

north ge08ff2fe4 1280

North Carolina PBM Reform Law Protects Certain 340B Covered Entity Types

Drug Pricing, News, RulingsBy Andrea JeriaOctober 8, 2021

On September 20, North Carolina enacted a PBM reform law, Session Law 2021-161, that includes provisions protecting certain categories of 340B covered entities against discriminatory practices.  The law protects federally…

united states supreme court 6330563 1920 1

Supreme Court to Review Three Cases With Implications for 340B Covered Entities

Drug Pricing, HIV/AIDS, News, RulingsBy adminJuly 7, 2021

The Supreme Court has agreed to review three cases in its next term that have potential impact on 340B covered entities. First, the Supreme Court will review AHA, et al.…

9 board of directors

Secretary of HHS Names ADR Board Members

Drug Pricing, HHS, HRSA, News, RulingsBy adminJune 28, 2021

As expected, on June 21, the Secretary of HHS appointed Alternative Dispute Resolution (ADR) Board members.  ADR Board members are government representatives (not private stakeholders) from three government agencies: HHS…

9 board of directors

HHS Appoints 340B ADR Board Members

Drug Pricing, HHS, HRSA, News, RulingsBy adminJune 18, 2021

The Powers team was informed today that the Secretary of HHS has signed a memorandum appointing members to the 340B Alternative Dispute Resolution Board (ADR Board).   Appointment of ADR Board…

pexels sora shimazaki 5668882

Filings in Drug Manufacturer Lawsuits Following HHS’s May 17 Letter

Drug Pricing, HHS, News, Rulings, RWC-340BBy adminMay 21, 2021

Following a favorable May 17 Letter (the “Letter”) issued by HHS requiring six drug companies to restart 340B pricing on drugs shipped to contract pharmacies or risk civil monetary penalties,…

Court Upholds Medicare Part B Reimbursement Cuts for 340B Drugs

Drug Pricing, News, Rulings, RWC-340BBy adminJuly 31, 2020

The Court of Appeals for District of Columbia Circuit issued a 2-1 decision today upholding Medicare Part B reimbursement cuts for 340B drugs from ASP+6% to ASP-22.5%.  The case is…

DC Circuit Rules on 340B Medicare Advantage Discriminatory Reimbursement Case

Drug Pricing, HHS, News, Rulings, RWC-340BBy adminJanuary 9, 2020

The federal appeals court for the District of Columbia Circuit recently ruled in favor of the Humana Medicare Advantage plan in a case by a 340B covered entity contending that…

→123→
                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset